Form 4: Ginkgo Bioworks Executive Acquires Restricted Stock Units
SEC Form 4 Filing
Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., acquired 4,245 restricted stock units (RSUs) on March 6, 2025, according to a Form 4 filing.
Summary
- Steven P. Coen, the Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., filed a Form 4 indicating a transaction involving the company's securities.
- On March 6, 2025, Coen acquired 4,245 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of Ginkgo Bioworks' Class A Common Stock.
- The RSUs vest in four equal installments: 25% on April 16, 2025, 25% on July 16, 2025, 25% on October 16, 2025, and 25% on January 16, 2026.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider transactions.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The acquisition of RSUs by a key executive could signal confidence in the company's future performance to shareholders.
- Employees may view this as a positive sign of management's commitment.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of transaction: acquisition of 4,245 Restricted Stock Units |
| 03/10/2025 | Date of Form 4 filing |
| 04/16/2025 | First vesting date for 25% of the RSUs |
| 07/16/2025 | Second vesting date for 25% of the RSUs |
| 10/16/2025 | Third vesting date for 25% of the RSUs |
| 01/16/2026 | Final vesting date for 25% of the RSUs |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.